Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Appl Radiat Isot ; 168: 109507, 2021 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-33317890

RESUMO

Theranostic applications of radiopharmaceuticals have revolutionized present era specially, dealing with cancer diseases. Increase in the uses of radionuclides in nuclear medicine has resulted in the demands of optimized new radionuclides to be produced focussing on the economy, simplicity and maximum yield. Two radionuclides of arsenic offer a well agreed theranostic systems namely 77As and 72As. Some arsenic radionuclides are capable of positron-emission, with range of hour to weeks half-lives and have potential to be used for nuclear medicine. Present work will elucidate the production of 72As on Germanium and Selenium via proton induced nuclear reactions. The experimental results obtained by several nuclear reactions were analyzed. The results of nuclear model codes namely ALICE-IPPE, EMPIRE-3.2.3 and TALYS-1.9 are compared with the experimental cross sections to generate recommended cross section data. Recommended excitation functions are used to compute the thick target yields (TTY) of 72As. Assessment of radionuclidic impurities are also studied and comparison of several radionuclidic impurities is done. To produce 72As,72Ge (p, n)72As, 73Ge (p, 2n)72As, 74Ge (p, 3n)72As and 76Se (p, x)72As reactions in different energy ranges are discussed. We have identified 72Ge (p, n)72As reaction; gives pre-eminent yield with least impurities mark it as feasible entrant to be applied in Positron Emission Tomography (PET) and theranostic applications.


Assuntos
Arsênio/química , Germânio/química , Medicina de Precisão , Radioisótopos/química , Selênio/química , Simulação por Computador , Tomografia por Emissão de Pósitrons
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA